Allogene Therapeutics (ALLO) Stock Chart & Stock Price History $1.82 -0.02 (-1.09%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Allogene Therapeutics Stock Price Performance 5 Day Performance-6.67%1 Month Performance-4.21%3 Month Performance-35.92%6 Month Performance-40.33%Year-To-Date Performance-14.55%1 Year Performance-43.13% Receive ALLO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Allogene Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address ALLO Stock Chart for Saturday, January, 18, 2025 ALLO Chart by TradingView Allogene Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization01/17/2025$1.84$1.82-1.09%$1.90$1.792.22 million shs$381.60 million01/16/2025$1.87$1.84-1.60%$1.88$1.812.28 million shs$385.79 million01/15/2025$1.92$1.87-2.60%$2.10$1.822.62 million shs$392.09 million01/14/2025$1.95$1.92-1.54%$2.06$1.906.14 million shs$402.57 million01/13/2025$2.06$1.95-5.34%$2.05$1.922.08 million shs$408.86 million01/10/2025$2.35$2.06-12.34%$2.30$2.053.14 million shs$431.92 million Get the Latest News and Ratings for ALLO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Allogene Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 01/09/2025$2.35$2.35$2.39$2.233.56 million shs$492.73 million01/08/2025$2.35$2.35$2.39$2.233.56 million shs$492.73 million01/07/2025$2.16$2.35+8.80%$2.41$2.154.21 million shs$492.73 million01/06/2025$2.16$2.16$2.25$2.112.01 million shs$452.89 million01/03/2025$2.20$2.16-1.82%$2.27$2.142.52 million shs$452.89 million01/02/2025$2.13$2.20+3.29%$2.35$2.123.45 million shs$461.28 million01/01/2025$2.13$2.13$2.19$2.062.14 million shs$446.60 million12/31/2024$2.10$2.13+1.43%$2.19$2.062.14 million shs$446.60 million12/30/2024$2.19$2.10-4.11%$2.17$1.993.12 million shs$440.31 million12/27/2024$2.17$2.19+0.92%$2.22$2.053.08 million shs$459.18 million12/26/2024$2.09$2.17+3.83%$2.17$2.002.86 million shs$454.99 million12/25/2024$2.09$2.09$2.10$1.911.81 million shs$438.21 million12/24/2024$1.95$2.09+7.18%$2.10$1.911.81 million shs$408.86 million12/23/2024$1.87$1.95+4.28%$1.96$1.833.17 million shs$408.86 million12/20/2024$1.84$1.87+1.63%$1.93$1.784.99 million shs$392.09 million12/19/2024$1.90$1.84-3.16%$1.92$1.782.93 million shs$385.80 million12/18/2024$2.07$1.90-8.21%$2.12$1.862.76 million shs$398.38 million12/17/2024$2.06$2.07+0.49%$2.08$1.992.21 million shs$434.02 million Related Companies ARQT Stock Chart GLPG Stock Chart INDV Stock Chart AKRO Stock Chart DYN Stock Chart IMCR Stock Chart EVO Stock Chart GPCR Stock Chart TVTX Stock Chart VIR Stock Chart Receive ALLO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Allogene Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ALLO) was last updated on 1/18/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredStunning Trump Exec Order LeakedMost people have no clue this unassuming facility exists. Yet the minute Donald Trump takes office... ...Banyan Hill Publishing | SponsoredBitcoin to $200K?Newsweek recently asked several analysts whether they think Bitcoin will hit $200,000 by the end of 2025. T...Stansberry Research | SponsoredElon's "Final Move" Could Send This Stock SoaringWhenever Elon Musk starts a new venture... Early investors get the opportunity to become millionaires... ...Behind the Markets | SponsoredThe Biggest Money-Making Idea in My 43 Years in the Stock MarketBillionaires and top investors - including the late great Charlie Munger - and many more names you would recog...The Oxford Club | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Allogene Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Allogene Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
